For GI applications, some practitioners recommend oral administration to maximize local gastrointestinal exposure
You or a caregiver should carefully monitor for these side effects, especially in the beginning of treatment and with dose changes
While there was a substantial increase over the ten-year period between 2012 and 2022, some evidence indicates that utilization has only continued to rise over the last two years, beyond the most recent claims data available
Overall, food cravings assessed during fasting also decreased with tirzepatide treatment compared with placebo, including cravings for sweets, high-fat food, carbohydrates, starches, and fast-food fats, while cravings for fruits and vegetables were not impacted by tirzepatide treatment